HOME >> BIOLOGY >> NEWS
Sahara's edge studied from ground, air and space to improve water management

An international team worked on the verge of the Sahara to gather data on the ground and in the air, to be compared with imagery of the same region acquired by ESA satellites. The results will be used in support of an ambitious project to apply satellite remote sensing to improve monitoring and management of vast water aquifers concealed beneath the desert.

High-resolution radar as well as hyperspectral optical imagery was acquired during flights across two test areas in southern Tunisia. Meanwhile ground teams precisely documented ground vegetation and terrain at sampling sites within these test areas, with samples taken to local laboratories for detailed analysis. And ESA's Envisat, ERS-2 and Proba satellites acquired images of these sites around the same time. The aim was to scale up the findings from the ground, and at the same time to use this 'ground truth' to calibrate satellite imagery with reality on the sandy arid ground as well as seeing what can be learnt about the water beneath it.

The Sahara has altered through the ages: during the last Ice Age, 10 000 years ago, there was savannah here with rivers, lakes and plentiful rains. That landscape has vanished now, but the rains from that period progressively percolated beneath the ground to be collected in layers of water-bearing rock known as aquifers.

This 'fossil water' is today used in North African nations for irrigating agriculture and to support population growth. It is a valuable resource but also a non-renewable one - distributed across national boundaries - which requires careful management to be employed in a sustainable way. Over-exploitation risks exhaustion of groundwater, plus loss of artesian pressure to put remaining supplies out of reach or induce contamination from nearby saline water deposits.

Working with partners including African water agencies, ESA has commenced a project called Aquifer to develop satellite-derived products and services to suppo
'"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-069-418-0856
European Space Agency
19-Dec-2005


Page: 1 2 3 4 5

Related biology news :

1. Bacterial response to oxidation studied as toxin barometer
2. Ground spider diversity studied in research project
3. Fat stem cells being studied as option for breast reconstruction
4. Area creek studied for rangeland effects on water quality
5. Links between DNA damage and breast cancer studied
6. Inflammation and drugs to control this activity studied in a variety of tumors sites
7. Atherosclerosis studied at the cellular level
8. OT, VP studied as novel psychiatric drug sources; consider gender-specific drug models
9. Novel biotoxin being studied for use in opioid withdrawal
10. Insecticide resistance in mosquitoes being studied
11. MIT: Recycling of scrapped electronics studied

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sahara edge studied from ground air and space improve water management

(Date:5/10/2015)... , May 11, 2015 Fingerprint ... sensors FPC1025 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... will be used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK for ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has announced ... Outlook 2020 " report to their offering. ... medicine is expected to have huge marketing potential. Presently, ... the growth of deregulated organs. Several therapeutic molecules are ... form new tissue or sometimes organ transplant is required. ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: